Page 30 - ANZCP Gazette November 2021

Shrimpton et al. 5
2. Spronk H, Wilhelm S, Van Oerle R, et al. Feedback acti- vation of factor XI by Thrombin is essential for hemosta- sis in vivo. Blood 2009; 114: 2127–2127.
12. Gerhardt MA, Greenberg CS, Slaughter TF, et al. Factor XII deficiency and cardiopulmonary bypass: use of a novel modification of the activated clotting time to moni- tor anticoagulation. Anaesthesiol Case Rep 1997; 87: 990–
3. Cronbaugh R, Fuller LA, Miller SDM, et al. Cardiopulmonary bypass in a patient with Factor XII 992.
deficiency. J Extra Corpor Technol 2014; 46: 251–253.
4. DeBois WLJ, Lee L, Girardi L, et al. Cardiopulmonary bypass in patients with pre-existing coagulopathy. J Extra
Corpor Technol 2005; 37: 15–22.
5. Wallock M, Arentzen C, Perkins J. Factor XII deficiency
and cardiopulmonary bypass. Perfusion 1995; 10: 13–16.
6. Candio J, Prager D. Cardiopulmonary bypass and Factor
XII deficiency. Pa Med 1981; 84: 40.
7. Burman JF, Chung HI, Lane DA, et al. Role of factor XII
in thrombin generation and fibrinolysis during cardio-
pulmonary bypass. Lancet 1994; 344: 1192–1193.
8. Moorman RM, Reynolds DS, Comunale ME.
13. Rygal P, Kuc A. Perioperative management of cardiac surgery patients with Factor XII deficiency - two cases report. Anaesthesiol Intensive Ther 2012; 44: 217–220.
14. Wood M. Congenital factor XII deficiency and cardio- pulmonary bypass. Ann Thorac Surg 1994; 58: 1565– 1565.
15. Van Veen J, Laidlaw S, Swanevelder J, et al. Contact fac- tor deficiencies and cardiopulmonary bypass surgery: detection of the defect and monitoring of heparin. Eur J Haematol 2008; 82: 208–212.
16. Uppal V, Rosin M. Factor XII deficiency and cardiopul- monary bypass. J Extra Corpor Technol 2014; 46: 254–
Management of cardiopulmonary bypass in a patient 257.
with congenital Factor XII deficiency. J Cardiothoracic
Vasc Anesth 1993; 7: 452–454.
9. Salmenpera M, Rasi V, Mattila S. Cardiopulmonary
bypass in a patient with Factor XII deficiency. Anesthesiol
Case Rep 1991; 75: 539–541.
10. Kelsey PR, Bottomley J, Grotte GJ, et al. Congenital
Factor XII deficiency: successful open heart surgery and
anticoagulation. Int J Lab Hematol 1985; 7: 379–381.
11. Finley A, Greenberg C. Heparin sensitivity and resist- ance: management during cardiopulmonary bypass.
Anesth Analg 2013; 116: 1210–1222.
17. Manlhiot C, Gruenwald CE, Holtby HM, et al. Challenges with heparin-based anticoagulation during cardiopul- monary bypass in children: impact of low antithrombin activity. J Thorac Cardiovasc Surg 2016; 151: 444–450.
18. Gruenwald C, Manlhiot C, Crawford-Lean L, et al. Management and monitoring of anticoagulation for chil- dren undergoing cardiopulmonary bypass in cardiac sur- gery. J Extra Corpor Technol 2010; 42: 9–19.
19. Chaudhry L, El-Sadek WYM, Chaudhry GA, et al. Factor XII (Hageman Factor) deficiency: a rare harbinger of life threatening complications. Pan Afr Med J 2019; 33: 39.
27 NOVEMBER 2021 | www.anzcp.org